This inventor holds 2 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignee: Yale University. Active years: 1998-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2000
Title: Mark Edward Fortini: Innovator in Cell Manipulation Technologies
Introduction
Mark Edward Fortini is a notable inventor based in New Haven, CT (US). He has made significant contributions to the field of cell biology, particularly in the manipulation of non-terminally differentiated cells. With a total of 2 patents, Fortini's work has the potential to impact regenerative medicine and gene therapy.
Latest Patents
Fortini's latest patents focus on the manipulation of non-terminally differentiated cells using Notch function agonists. The inventions are directed towards methods for expanding precursor cells while inhibiting their differentiation. This allows for the proliferation of stem or progenitor cells, which can be utilized in cell replacement therapy. The expanded cell populations can also be made recombinant for gene therapy applications or used to provide specific functions associated with precursor cells.
Career Highlights
Mark Edward Fortini is affiliated with Yale University, where he conducts his research and development in cell manipulation technologies. His work is at the forefront of innovative approaches to cell therapy, aiming to regenerate diseased or injured tissues effectively.
Collaborations
Fortini has collaborated with esteemed colleagues such as Spyridon Artavanis-Tsakonas and Kenji Matsuno. These collaborations have further enriched his research and contributed to advancements in the field.
Conclusion
Mark Edward Fortini's innovative work in the manipulation of non-terminally differentiated cells positions him as a key figure in the advancement of regenerative medicine. His contributions are paving the way for new therapies that could significantly improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
